Target-guided synthesis (TGS) is an innovative approach in drug discovery that focuses on the direct interaction between a biological target and small molecule fragments. This method allows ...

A new study from the Kowalinski group at EMBL Grenoble characterized the structure of an important trypanosomal protein ...

Discover key considerations for executing workflows in drug discovery, from defining research questions and generating ...

With the use of deep learning and advanced algorithms, generative AI can promote acceleration in the design and development ...

Rancho BioSciences, the premier tech-enabled data science partner for biopharma, headquartered in San Diego, California, is ...

Further, this segment is classified into drug discovery target identification & validation lead identification & optimization de novo drug design. Some other major drivers for the drug discovery ...

Insilico Medicine (“Insilico”), a clinical stage generative artificial intelligence (AI)-driven biotechnology company has ...

By leveraging this capability, AlphaMeld Corporation has successfully progressed several candidates from target identification ... This model has led to the discovery of novel targets which have now ...

Enhanc3D Genomics (‘Enhanced’), an innovator in 3D genomics technology, today announced the launch of a suite of integrated multi-omics solutions to accelerate and improve the precision of drug ...

The convergence of AI, accelerated computing and biological data is turning healthcare into the largest technology industry.

Rancho Biosciences will leverage its expertise in subject matter expert data processing and curation to prepare a wide range of life science datasets-including clinical, single cell, spatial, genomic, ...